Masato Takahashi, Eriko Tokunaga, Joji Mori, Yoshinori Tanizawa, Jan-Stefan van der Walt, Tsutomu Kawaguchi, Matthew P Goetz, Masakazu Toi. Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Breast cancer (Tokyo, Japan). 2022. 29. 1. 174-184
Hiroyuki Inoue, Tsutomu Kawaguchi, Hisashi Ikoma, Ryo Morimura, Yusuke Yamamoto, Toshiya Ochiai, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, et al. Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy. Journal of surgical oncology. 2021. 124. 5. 791-800
Aparna Maiti, Ichiro Okano, Masanori Oshi, Maiko Okano, Wanqing Tian, Tsutomu Kawaguchi, Eriko Katsuta, Kazuaki Takabe, Li Yan, Santosh Patnaik, et al. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs. Cancers. 2021. 13. 11
Kenichi Inoue, Norikazu Masuda, Hiroji Iwata, Masato Takahashi, Yoshinori Ito, Yasuo Miyoshi, Takahiro Nakayama, Hirofumi Mukai, Jan-Stefan van der Walt, Joji Mori, et al. Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy. Breast cancer (Tokyo, Japan). 2021. 28. 5. 1038-1050
Masanori Oshi, Tsutomu Kawaguchi, Li Yan, Xuan Peng, Qianya Qi, Wanqing Tian, Amy Schulze, Kerry-Ann McDonald, Sumana Narayanan, Jessica Young, et al. Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer. American journal of cancer research. 2021. 11. 7. 3628-3644
